European Pharmaceutical Review

JANUARY 9, 2024

Adding these developments with the addition of connected IoT devices, supply chain restructuring and consideration for our code of ethics will give us a glimpse at how pharmaceutical production will look in future. 2016; 85(4):2048-2050. 2016; 12(7):878. Eur J Radiol. Jamshidi N, Eslami M. J Am Coll Radiol. Mol Syst Biol.

Pharmaceutical manufacturing 122

Pharmaceutical manufacturing Manufacturing Pharmaceutical Food and Drug Administration 122

pharmaphorum

JULY 27, 2022

The association also said that the UK’s exports and imports of pharmaceutical products were notably lower than those of the majority of comparators. These values have seen a year-on-year decline since 2016 for exports and 2015 for imports, in contrast with a general upward trend seen in most comparator countries, said the ABPI. “It

Government 98

Government Recruitment Medicine Patients 98

PharmaKinnex

AUGUST 23, 2022

The pharmaceutical industry of 2022 is very different from the space that we all knew in 2012, 2016, or even 2020. PharmaKinnex knows that identifying, qualifying, and then directing leads toward a successful sale is extremely difficult in today’s environment. The Traditional Pharma Model Isn’t Working – It’s Time to Evolve!

Pharma 52

Pharma Sales Sales Strategy Marketing 52

European Pharmaceutical Review

JUNE 24, 2022

This means numerous key aspects of how pharmaceuticals are regulated in the EU could be affected, from costing and reimbursement to intellectual property rights, incentives and more. Stakeholders in the EU often use the risk-adjusted Net Present Value (rNPV) investment model to determine whether to invest in a pharmaceutical product.

Pharmaceutical 105

Pharmaceutical Medicine Marketing Competition 105

European Pharmaceutical Review

FEBRUARY 3, 2025

The firm failed to properly integrate co-eluting peaks during impurity testing of phentermine HCL capsules, which lead to undetected out-of-specification (OOS) results for at least one production batch, which remained on the market despite the company identifying the problem in 2016.

Manufacturing 88

Manufacturing Food and Drug Administration FDA Food 88

European Pharmaceutical Review

APRIL 8, 2025

Oliver Steinhof currently leads the PAT Implementation team in biologics analytical R&D at MSD and holds a diploma in inorganic chemistry from Technische Universitt Brauschweig. He holds a BSc in chemical & pharmaceutical sciences and a PhD in chemo/biosensor design and characterisation, both from Dublin City University.

Manufacturing 52

Manufacturing Food and Drug Administration Management Pharmaceutical 52